ArticleInternal medicine (Tokyo, Japan)2018

Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of Life.

Megumi Kawakubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.